Physician profile
Jeffrey Hill
NPI 1770894362
$629.83
in general payments reported to CMS, 2019-2025
19 companies · $29.76 in 2025
The $29.76 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $281 · 2021: $48.09 · 2025: $29.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $29.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $96.39 | 2019 | |
| Glaxosmithkline, LLC. | $66.33 | 2019-2020 | |
| Eisai INC. | $50.66 | 2020 | |
| Organogenesis INC. | $48.44 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.43 | 2019-2020 | |
| Novo Nordisk INC | $34.35 | 2019-2020 | |
| Abbvie INC. | $33.74 | 2019-2020 | |
| Amarin Pharma, INC. | $30.34 | 2019-2021 | |
| Astellas Pharma US INC | $29.76 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $29.34 | 2019-2020 | |
| Amgen INC. | $27.02 | 2020 | |
| Fidia Pharma USA INC. | $26.21 | 2019 | |
| Radius Health, INC. | $22.14 | 2021 | |
| Arbor Pharmaceuticals, INC. | $19.39 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $17.43 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.38 | 2019 | |
| Bausch Health US, LLC | $13.09 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.87 | 2021 | |
| Ferring Pharmaceuticals INC. | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.